40-GEP Test Utilization Can Mitigate Financial Burden of Cutaneous Squamous Cell Carcinoma
Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC) could save on health care costs by utilizing the 40-gene expression profile (40-GEP) to guide treatment decisions.
Source: ajmc.com